An application made for this job — a tailored resume and cover letter that speak straight to the posting.
CSL Seqirus seeks a Principal Clinical Scientist to lead clinical studies end-to-end, from protocol development through data interpretation and final reporting, in a hybrid setup across Maidenhead, UK, Melbourne, and Zurich. The role emphasizes scientific leadership and close collaboration with CROs and cross-functional teams.
Applicants should bring hands-on study experience, ability to write study protocols and reports, and a track record in outsourced operating models.
We're looking for a clinical scientist - someone who has been the scientific lead for clinical studies before, from protocol development to start-up (development of critical study documents) through to study execution, data analysis and interpretation and close-out with a clinical study report. Having prepared regulatory submissions of study results is a pre. You'll work in close partnership with the clinical operations team and CROs under the team's full-outsource operating model, managing that day-to-day relationship rather than delivering trial activity in-house. It's one of two newly approved roles, created ahead of anticipated demand rather than to backfill a departure, which means there's genuine room to help shape how the team works rather than simply joining an existing structure.
Hybrid based (3 days a week onsite) in Maidenhead (UK), Melbourne (Aus) or Zurich (CH)
A clinical study is only as good as the people running it. A weak protocol, poorly managed start-up, or a fumbled relationship with the CRO delivering the trial can cost a program months - sometimes far more - and that delay sits between a therapy and the patients waiting on it. This role exists because CSL is adding capacity to get that execution right: someone who can lead all scientific needs of a study properly, and co-own the end to end alongside clinical operations, is what actually moves a clinical development plan forward. It's not a supporting or administrative function - it's the core that determines whether the science translates into a trial that runs cleanly and data that holds up.
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ .
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL .
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement .